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1School of Biosciences, University of Kent,
Canterbury, United KingdomNucleation is a process that initiates
phase transitions. Since the classical
work of Gibbs on nucleation thermody-
namics at the end of the nineteenth cen-
tury, research into nucleation processes
has been spread into a huge variety of
scientific fields. To date, nucleation has
been studied in disciplines ranging
from biophysics to cosmology in sys-
tems spanning atomic to planetary
scales and beyond (1). Proteins in solu-
tion are also known historically to form
a variety of states and structures through
nucleation (2,3). In the past twodecades,
the assembly of proteins into highly
ordered amyloid fibrils associated
with numerous human diseases such as
Alzheimer’s disease, Parkinson’s dis-
ease, and Type II diabetes mellitus has
sparked renewed interest in theory
development, which has resulted in
new kinetic models of protein fibril as-
sembly (4,5). With these new develop-
ments, nucleation has again come to
the fore in protein biophysics through
the nucleated processes in which super-
saturated solutions of proteins form
insoluble supramolecular protein ag-
gregates consisting of amyloid fibrils,
which are defined by their highly or-
dered cross-b conformation (6). Thus,
amyloid assembly converts soluble pro-
teins into insoluble fractions that can be
associated with human diseases, and the
nucleation mechanism that initiates this
phase transition represents a hitherto un-
resolved process of medical and funda-
mental biophysical importance.
In this issue of the Biophysical
Journal, Kashchiev (7) presents a theo-http://dx.doi.org/10.1016/j.bpj.2015.10.011
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nucleation theory to a simple one-
dimensional polymerization model,
the Oosawa-Kasai model that describes
the formation of linear and helical poly-
mers. The thermodynamics and kinetics
of three versions of such one-dimen-
sional polymerization in terms of their
homogeneous nucleation properties
were evaluated. With this approach,
the nucleation behavior of the polymer-
ization models, or lack thereof, was
assessed rigorously. Formulae for key
thermodynamic quantities such as nu-
cleus size, polymerization work, nucle-
ation rate, and the nucleation energy
barrier were derived for the models.
Here, Kashchiev sets an important
example on how classical nucleation
theory can be applied to protein fibril
formation. By showing how the thermo-
dynamics and kinetics of protein fibril
nucleation can be evaluated in a concep-
tually straightforwardmanner, he offers
a critical perspective that links new
kinetic models of protein polymeriza-
tion with the classic thermodynamics
and kinetics results offered by the phys-
ical chemistry of nucleation.
With this work, Kashchiev sets new
challenges and offers new opportunities
toward resolving the initial molecular
steps in the mechanism of fibrous pro-
tein polymerization and amyloid forma-
tion. Firstly, this work sets a renewed
challenge for researchers to design new
experiments with sufficient informa-
tion content and analysis approaches
that can be used to validate protein
nucleation models. For example, the
approach used by Kashchiev predicts
stationary prenuclei species (subnuclei)
distribution and nucleation rates that
could be observed and measured. In
experimental studies of protein fibril as-
sembly, direct or indirect observations
of nucleation processes (red and purple
arrows in Fig. 1) are, arguably, the
most challenging to achieve compared
to the other main processes involved
(blue and orange arrows in Fig. 1).
New experimental approaches such as
microfluidics-based assays, fluores-
cence methods, and multimethod com-binations, which allow novel detection
of early monomer interactions, single
nucleation events, and rare prenucleus
species (4,8–10) may resolve themolec-
ular mechanism of protein nucleation
with the help from the theoretical
framework laid down here by Kash-
chiev. Secondly, the process of second-
ary nucleation (Fig. 1, purple arrow)
has been implicated as a key factor
that accelerates formation of disease-
associated protein fibrils and produces
potentially cytotoxic species (9). These
secondary nucleation events are hetero-
geneous nucleation processes occurring
on the surfaces of preformed aggre-
gates. In addition, heterogeneous nucle-
ation may occur at the numerous
biological interfaces or artificially intro-
duced solid-liquid/air-liquid interfaces
in vivo and in vitro, which results in
accelerated primary nucleation (Fig. 1,
red arrows). In both cases, interfaces
may catalyze heterogeneous nuclea-
tion of amyloid in a way explained by
the so-called wetting phenomenon.
Thereby, these key surface reactions
can be described thermodynamically
and kinetically by the same framework
used by Kashchiev here for homoge-
neous nucleation (1,7). Understanding
the thermodynamic origin of these
surface-catalyzed nucleation reactions
will be particularly important in
resolving why certain amyloid aggre-
gates catalyze secondary nucleation on
their surfaces and how potentially dis-
ease-associated heterogeneous nucle-
ation events can be avoided or
inhibited. Thirdly, Kashchiev discussed
the Oosawa-Kasai model of helical
polymerization, which provides a struc-
tural explanation of how small prenu-
cleus species (subnuclei) can be less
stable than postnucleus species (super-
nuclei), and therefore how nucleation
might occur during the formation of
pseudo one-dimensional protein poly-
mers. Thismodel provides an interesting
idea in the case of amyloid polymeriza-
tion and suggests that small prenucleus
FIGURE 1 Schematic illustration of the lifecycle of amyloid. (Circles) Soluble monomeric protein.
(Parallelograms) Monomeric units in the amyloid cross-b conformation. (Colored arrows) Main pro-
cesses in amyloid assembly. (Red arrows) Primary nucleation, which may occur as homogeneous
nucleation in solution or heterogeneous nucleation at interfaces. (Purple arrow) Secondary nucleation,
which may occur as heterogeneous nucleation at surfaces presented by preformed aggregates. (Blue
and orange arrows) Key nonnucleation based processes elongation growth, and breakage division,
respectively. (Single arrows may represent multiple consecutive steps; arrow thickness symbolizes
relative rates involved in the processes.) To see this figure in color, go online.
2000 Xueoligomeric species may switch to and
from an amyloid conformation during
the nucleation process. While this type
of model is still limited in scope, the
approach is flexible enough to allow ex-
pansions aimed to resolve whether the
nucleation of any fibrillar protein aggre-
gate is dominated by the increased sta-
bility that the cross-b conformation of
the peptide chains confer, by the number
of molecules present in the clusters, or
by a combination of both.
Ultimately, nucleated polymeriza-
tion of proteins into ordered amyloid
fibrils has a dimension of added
complexity owning to the required
structural transition from globular or
intrinsically disordered states to the
cross-b conformation that defines
the amyloid structure (10,11). This
complexity is not yet fully captured by
existing nucleation models. Conse-
quently, how amyloid structural poly-
morphism, species barrier, and strains
phenomenon originate in relation to
primary nucleation and secondary
aggregate surface mediated heteroge-Biophysical Journal 109(10) 1999–2000neous nucleation is not resolved. Kash-
chiev’s approach, therefore, presents
an elegant generalization that has the
potential to unify theories of homoge-
neous and heterogeneous protein nucle-
ation, and offers a new opportunity to
examine the fundamental thermody-
namic basis of the birth of early amy-
loid species that dictates the final
structures and functions of the fibril
products. Recently, a hypothesis has
been laid out, proposing the existence
of a prebiotic amyloid world (6). ‘‘The
amyloid world’’ hypothesis suggests
that the protein assemblies with the
cross-b amyloid conformation were
the first self-propagating and informa-
tion carrying biomolecules, which are
preserved today as epigenetic informa-
tion carriers. Kashchiev commented in
his book on nucleation: ‘‘it should not
be a surprise if it proves that even the
Big Bang was a nucleation phenome-
non’’ (1). Likewise, fundamental mech-
anistic understanding of nucleation
underlying the birth of ordered protein
fibrils may too not surprisingly suggestthat even the evolution of early life
started as a nucleation phenomenon.ACKNOWLEDGMENTS
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